Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: An alteration not due to hyperglycemia

Robert Considine, Mark R. Nyce, Lonnie E. Allen, Luz Marina Morales, Stuart Triester, Jose Serrano, James Colberg, Susan Lanza-Jacoby, Jose F. Caro

Research output: Contribution to journalArticle

129 Citations (Scopus)

Abstract

We tested the hypothesis that liver protein kinase C (PKC) is increased in non-insulin-dependent diabetes mellitus (NIDDM). To this end we examined the distribution of PKC isozymes in liver biopsies from obese individuals with and without NIDDM and in lean controls. PKC isozymes α, β, ε and ζ were detected by immunoblotting in both the cytosol and membrane fractions. Isozymes γ and δ were not detected. There was a significant increase in immunodetectable PKC-α (twofold), -ε (threefold), and -ζ (twofold) in the membrane fraction isolated from obese subjects with NIDDM compared with the lean controls. In obese subjects without NIDDM, the amount of membrane PKC isozymes was not different from the other two groups. We next sought an animal model where this observation could be studied further. The Zucker diabetic fatty rat offered such a model system. Immunodetectable membrane PKC-α, -β, -ε, and -ζ were significantly increased when compared with both the lean and obese controls. The increase in immunodetectable PKC protein correlated with a 40% elevation in the activity of PKC at the membrane. Normalization of circulating glucose in the rat model by either insulin or phlorizin treatment did not result in a reduction in membrane PKC isozyme protein or kinase activity. Further, phlorizin treatment did not improve insulin receptor autophosphorylation nor did the treatment lower liver diacylglycerol. We conclude that liver PKC is increased in NIDDM, a change that is not secondary to hyperglycemia. It is possible that PKC-mediated phosphorylation of some component in the insulin signaling cascade contributes to the insulin resistance observed in NIDDM.

Original languageEnglish (US)
Pages (from-to)2938-2944
Number of pages7
JournalJournal of Clinical Investigation
Volume95
Issue number6
StatePublished - Jun 1995
Externally publishedYes

Fingerprint

Hyperglycemia
Type 2 Diabetes Mellitus
Protein Kinase C
Liver
Isoenzymes
Phlorhizin
Membrane Proteins
Membranes
Insulin
Diglycerides
Insulin Receptor
Immunoblotting
Cytosol
Protein Kinases
Insulin Resistance
Animal Models
Phosphorylation
Biopsy
Glucose

Keywords

  • Insulin resistance
  • Liver
  • PKC isozymes
  • ZDF rat

ASJC Scopus subject areas

  • Medicine(all)

Cite this

Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus : An alteration not due to hyperglycemia. / Considine, Robert; Nyce, Mark R.; Allen, Lonnie E.; Morales, Luz Marina; Triester, Stuart; Serrano, Jose; Colberg, James; Lanza-Jacoby, Susan; Caro, Jose F.

In: Journal of Clinical Investigation, Vol. 95, No. 6, 06.1995, p. 2938-2944.

Research output: Contribution to journalArticle

Considine, R, Nyce, MR, Allen, LE, Morales, LM, Triester, S, Serrano, J, Colberg, J, Lanza-Jacoby, S & Caro, JF 1995, 'Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: An alteration not due to hyperglycemia', Journal of Clinical Investigation, vol. 95, no. 6, pp. 2938-2944.
Considine, Robert ; Nyce, Mark R. ; Allen, Lonnie E. ; Morales, Luz Marina ; Triester, Stuart ; Serrano, Jose ; Colberg, James ; Lanza-Jacoby, Susan ; Caro, Jose F. / Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus : An alteration not due to hyperglycemia. In: Journal of Clinical Investigation. 1995 ; Vol. 95, No. 6. pp. 2938-2944.
@article{53362a34e3a74e9abb8b237fd8396395,
title = "Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus: An alteration not due to hyperglycemia",
abstract = "We tested the hypothesis that liver protein kinase C (PKC) is increased in non-insulin-dependent diabetes mellitus (NIDDM). To this end we examined the distribution of PKC isozymes in liver biopsies from obese individuals with and without NIDDM and in lean controls. PKC isozymes α, β, ε and ζ were detected by immunoblotting in both the cytosol and membrane fractions. Isozymes γ and δ were not detected. There was a significant increase in immunodetectable PKC-α (twofold), -ε (threefold), and -ζ (twofold) in the membrane fraction isolated from obese subjects with NIDDM compared with the lean controls. In obese subjects without NIDDM, the amount of membrane PKC isozymes was not different from the other two groups. We next sought an animal model where this observation could be studied further. The Zucker diabetic fatty rat offered such a model system. Immunodetectable membrane PKC-α, -β, -ε, and -ζ were significantly increased when compared with both the lean and obese controls. The increase in immunodetectable PKC protein correlated with a 40{\%} elevation in the activity of PKC at the membrane. Normalization of circulating glucose in the rat model by either insulin or phlorizin treatment did not result in a reduction in membrane PKC isozyme protein or kinase activity. Further, phlorizin treatment did not improve insulin receptor autophosphorylation nor did the treatment lower liver diacylglycerol. We conclude that liver PKC is increased in NIDDM, a change that is not secondary to hyperglycemia. It is possible that PKC-mediated phosphorylation of some component in the insulin signaling cascade contributes to the insulin resistance observed in NIDDM.",
keywords = "Insulin resistance, Liver, PKC isozymes, ZDF rat",
author = "Robert Considine and Nyce, {Mark R.} and Allen, {Lonnie E.} and Morales, {Luz Marina} and Stuart Triester and Jose Serrano and James Colberg and Susan Lanza-Jacoby and Caro, {Jose F.}",
year = "1995",
month = "6",
language = "English (US)",
volume = "95",
pages = "2938--2944",
journal = "Journal of Clinical Investigation",
issn = "0021-9738",
publisher = "The American Society for Clinical Investigation",
number = "6",

}

TY - JOUR

T1 - Protein kinase C is increased in the liver of humans and rats with non-insulin-dependent diabetes mellitus

T2 - An alteration not due to hyperglycemia

AU - Considine, Robert

AU - Nyce, Mark R.

AU - Allen, Lonnie E.

AU - Morales, Luz Marina

AU - Triester, Stuart

AU - Serrano, Jose

AU - Colberg, James

AU - Lanza-Jacoby, Susan

AU - Caro, Jose F.

PY - 1995/6

Y1 - 1995/6

N2 - We tested the hypothesis that liver protein kinase C (PKC) is increased in non-insulin-dependent diabetes mellitus (NIDDM). To this end we examined the distribution of PKC isozymes in liver biopsies from obese individuals with and without NIDDM and in lean controls. PKC isozymes α, β, ε and ζ were detected by immunoblotting in both the cytosol and membrane fractions. Isozymes γ and δ were not detected. There was a significant increase in immunodetectable PKC-α (twofold), -ε (threefold), and -ζ (twofold) in the membrane fraction isolated from obese subjects with NIDDM compared with the lean controls. In obese subjects without NIDDM, the amount of membrane PKC isozymes was not different from the other two groups. We next sought an animal model where this observation could be studied further. The Zucker diabetic fatty rat offered such a model system. Immunodetectable membrane PKC-α, -β, -ε, and -ζ were significantly increased when compared with both the lean and obese controls. The increase in immunodetectable PKC protein correlated with a 40% elevation in the activity of PKC at the membrane. Normalization of circulating glucose in the rat model by either insulin or phlorizin treatment did not result in a reduction in membrane PKC isozyme protein or kinase activity. Further, phlorizin treatment did not improve insulin receptor autophosphorylation nor did the treatment lower liver diacylglycerol. We conclude that liver PKC is increased in NIDDM, a change that is not secondary to hyperglycemia. It is possible that PKC-mediated phosphorylation of some component in the insulin signaling cascade contributes to the insulin resistance observed in NIDDM.

AB - We tested the hypothesis that liver protein kinase C (PKC) is increased in non-insulin-dependent diabetes mellitus (NIDDM). To this end we examined the distribution of PKC isozymes in liver biopsies from obese individuals with and without NIDDM and in lean controls. PKC isozymes α, β, ε and ζ were detected by immunoblotting in both the cytosol and membrane fractions. Isozymes γ and δ were not detected. There was a significant increase in immunodetectable PKC-α (twofold), -ε (threefold), and -ζ (twofold) in the membrane fraction isolated from obese subjects with NIDDM compared with the lean controls. In obese subjects without NIDDM, the amount of membrane PKC isozymes was not different from the other two groups. We next sought an animal model where this observation could be studied further. The Zucker diabetic fatty rat offered such a model system. Immunodetectable membrane PKC-α, -β, -ε, and -ζ were significantly increased when compared with both the lean and obese controls. The increase in immunodetectable PKC protein correlated with a 40% elevation in the activity of PKC at the membrane. Normalization of circulating glucose in the rat model by either insulin or phlorizin treatment did not result in a reduction in membrane PKC isozyme protein or kinase activity. Further, phlorizin treatment did not improve insulin receptor autophosphorylation nor did the treatment lower liver diacylglycerol. We conclude that liver PKC is increased in NIDDM, a change that is not secondary to hyperglycemia. It is possible that PKC-mediated phosphorylation of some component in the insulin signaling cascade contributes to the insulin resistance observed in NIDDM.

KW - Insulin resistance

KW - Liver

KW - PKC isozymes

KW - ZDF rat

UR - http://www.scopus.com/inward/record.url?scp=0029055746&partnerID=8YFLogxK

UR - http://www.scopus.com/inward/citedby.url?scp=0029055746&partnerID=8YFLogxK

M3 - Article

C2 - 7769136

AN - SCOPUS:0029055746

VL - 95

SP - 2938

EP - 2944

JO - Journal of Clinical Investigation

JF - Journal of Clinical Investigation

SN - 0021-9738

IS - 6

ER -